key: cord-0976019-cprjlzp0
authors: Ibrahim, Iman Hassan; El-lakwa, Doha El-Sayed
title: SUMO pathway, blood coagulation and oxidative stress in SARS-CoV-2 infection
date: 2021-02-03
journal: Biochem Biophys Rep
DOI: 10.1016/j.bbrep.2021.100938
sha: 5351a4cb4e442c67555f15ff8d6db3e76210e82b
doc_id: 976019
cord_uid: cprjlzp0

Severe Acute Respiratory Syndrome Corona Virus 2 (SARS CoV-2) is currently an international pandemic causing coronavirus disease 19 (COVID-19). Viral entry requires ACE2 and transmembrane protease serine 2 (TMPRSS2) for membrane fusion or through endosomal pathway. This Study aims to assess transcriptomic changes and differentially expressed genes (DFGs) in COVID-19. METHODS: Transcriptomic data of the publicly available dataset (GSE147507) was quantile normalized and analysed for DFGs, network analysis and pathway analysis. RESULTS: DFG sets showed that 8 genes (SAE1, AEBP2, ATP1A1, DKK3, MAFF, NUDC, TRAP1, and VAV1) were significantly dysregulated in all studied groups. Functional analysis revealed that negative regulation of glucocorticoid biosynthesis, protein SUMOylation (SAE1), blood coagulation (VAV1) and cellular response to stress were affected by SARS CoV-2 infection. Cell line transduction with ACE2 vector didn't show significant changes in the dysregulated pathways. Also, no significant change was observed in expression levels of ACE2 or TMPRSS2 in response to SARS CoV-2 infection. Further analysis showed dysregulation of several genes in the SUMOylation pathway and blood coagulation process in human and cell lines transcriptome. Also, several Cathepsins proteases were significantly dysregulated in case of SARS CoV-2 infection. Genes related to cellular response to stress such as TRAP-1 and NOX were dysregulated in cases of SARS CoV-2 infection. CONCLUSION: Dysregulation in genes of protein SUMOylation, blood coagulation and response to oxidative stress pathways in SARS CoV-2 infection could be critical for disease progression. Drugs acting on SUMO pathway, VAV1, NOX genes could be studied for potential benefit to COVID-19 patients.

Severe Acute Respiratory Syndrome Corona Virus 2 (SARS CoV-2) is currently an international pandemic causing coronavirus disease 19 . Genome of SARS CoV-2 codes for four main structural proteins: spike (S), nucleocapside (N), membrane (M) and envelope (E) proteins. The S protein is responsible for viral entry in host cells through interaction with angiotensin-converting enzyme 2 (ACE2). ACE2 is a zinc containing metallo-enzyme expressed in the cell membrane of several tissues including lung epithelium. Viral and cell membrane fusion requires host transmembrane protease serine 2 TMPRSS2 [1] . Both ACE and TMPRSS2 could be potential therapeutic targets for COVID-19. Serious clinical manifestations of COVID-19 include severe respiratory symptoms and irregular blood coagulation in COVID-19 that leads to a significantly increased risk of heart attacks and strokes [2] . These serious manifestations along with the absence of effective therapy dictate the need to suggest more potential target pathways.

This Study aims to assess transcriptomic changes in response to SARS CoV-2 infection in patients and several human cell lines. The differentially expressed genes (DFGs) could give an insight in molecular pathogenesis of COVID-19.

Transcriptomic data of the publicly available dataset (GSE147507) [3] was analysed focusing on particular four subsets including cell lines of primary human lung epithelium (NHBE), transformed lung alveolar (A549), and A549 transduced with a vector expressing human ACE2 (A549/ACE2), with or without SARS-CoV-2 infection. In addition, transcriptomic data from uninfected human lung biopsies and lung samples from COVID-19 patient was analysed.

After determining DFGs either over expressed or under-expressed, the DEGs lists were analysed using several bioinformatics tools including network analysis of protein-protein interactions and functions by STRING [4] . Protein -protein interaction enrichment p-value < 0.05 was considered significant. Strength of the enrichment was calculated using the formula:

Log10 (observed / expected) for proteins to be annotated with each term in the gene list compared to random network of the same size. Also, PANTHER [5] and Reactome [6] were used for pathway analysis. PANTHER tool was used to analyse the DEGs list based on annotation classification for molecular function, biological process, and pathways. In Reactome pathway analysis, a statistical hypergeometric distribution test was performed to determine whether or not certain pathways are enriched in the submitted DEG list. The probability score calculated is corrected for false discovery rate (FDR) using the Benjamani-Hochberg method as described below. FDR <0.05 for pathway enrichment probability score was considered significant.

Raw read counts were of the dataset GSE147507 were quantile normalized prior to analysis.

Student's T test was performed to determine the DFGs. P values were corrected for multiple testing (and represented as Q value) using Benjamini Hochberg method. Q value <0.05 was considered statistically significant. Benjamini Hochberg method was performed using the following formula: (i/20)*0.2 where i = rank of p-value.

Analysis of transcriptomic data of the four studied subsets revealed DEGs that were further analyzed using Reactome to determine the most significant dysregulated pathways (p-value <0.05) after SARS COV-2 infection or transfection (Table 1) .

For both types of A549 cell line (A549 and A549/ACE2) the DEGs (p-value <0.05) mostly belong to similar pathways.

Regarding human cells and NHBE cell line, the most significant dysregulated pathways were related to immunity and viral replication.

Lists of DEGs from the four studied group were compared to determine dysregulated genes in all the four groups. Only 8 significantly dysregulated genes (namely SAE1, AEBP2, ATP1A1, DKK3, MAFF, NUDC, TRAP1, and VAV1) were dysregulated in all the four groups ( Fig.1) .

Predicted protein functional analysis performed with STRING for the 8 genes showed relation to negative regulation of glucocorticoid biosynthetic process GO:0031947 (ATP1A1 and DKK3, FDR = 0.0016). Further analysis showed relation to protein SUMOylation GO: 0016925 (SAE1, FDR = 0.0017), and blood coagulation process GO: 0007596 (VAV1, and MAFF, FDR = 0.023).

Gene lists of the three GO processes were compared to DEGs in the four studied groups (Table 2) . Several genes of the three pathways were dysregulated. While the DEGs profiles were alike in negative regulation of glucocorticoid biosynthetic process, the DEGs related to protein SUMOylation and blood coagulation were quite different across the four studied groups.

For all studied groups, sets of DEGs were analyzed for the expression of genes involved in 

Genes related to cellular response to oxidative stress (such as the NOX genes (NADPH oxidase complex) and C5aR2) were dysregulated in cases of SARS CoV-2 infection (Qvalue <0.05).

Although ACE2 plays an important role in SARS CoV-2 molecular pathogenesis, the results of the current study showed that the expression of ACE2 didn't have much impact on neither the cell line transcriptome nor the pathways of DEGs. Pathway analysis of the transcriptome for the four studied subsets showed that the most significant dysregulated pathways in both A549 and A549/ACE2 after SARS CoV-2 transduction were quite similar. This could suggest that ACE2 expression although related to viral entry doesn't play major role in the disease molecular pathogenesis. This came in contradiction with previous reports that been identified as the specific binding partner of Nef proteins from HIV-1 [22] .

In the current study, VAV1 was overexpressed in association with SARS CoV-2 infection.

Azathioprine, which is a potent anti-inflammatory and immune suppressant, was reported to inhibit VAV1 functions in human patients [23] . However, whether or not this inhibition would improve COVID-19 patients needs further studies. Cathepsin F, which participates in intracellular degradation and turnover of proteins, was found in the current study to be downregulated with SARS CoV-2 infection. Cathepsin F was previously reported to be upregulated by angiotensin II which also increase the secretion of Cathepsin F in a mechanism involving angiotensin II receptors [30] .

It should be noted that SARS CoV-2 virus may enter the cells through endosomal uptake. In fact, direct entry from the cell surface or early endosomes was reported to be the preferred way of viral entry in vivo [31] . Endosomal vesicles within the cells form contain several classes of proteolytic enzymes, including cathepsins [32] . Collectively, these studies along with the current study results add more evidence to the importance of cathepsines in viral entry through ACE2 or endosomes.

Nuclear distribution gene C (NudC) was shown in the current study to be significantly dysregulated in SARS CoV-2 infection in all studied groups. Several studies had pointed out the importance of the of intracellular transport motors dynein and kinesin in viral life cycle. These motors are critical for replication and spread of many viruses via transport on microtubules. Different binding and regulatory proteins including Nud family interact with a J o u r n a l P r e -p r o o f specific subunits in the dynein motor complex [33] . NudC also plays important roles in cell migration, ciliogenesis, thrombopoiesis, and the inflammatory response [34] . Effect of NudC dysregulation on microtubule transport of the virus needs further study.

No significant change in expression levels of ACE2, TMPRSS2, ANGPT, AT1 was observed in relation to SARS CoV-2 infection in any studied group. Human ACE2 is known to be the receptor responsible of SARS-CoV-2 entry. The entry in cells was reported to require the action of a protease such as TMPRSS2 [35] . TMPRSS2 inhibitors such as camostat mesylate were reported to block SARS-CoV-2 entry in lung cells in vitro [36] . The absence of differential expression of ACE2 and TMPRSS2 in SARS CoV-2 groups suggests that their concentrations don't correlate with viral growth and disease progression.

In the current study, several genes related to cellular response to stress (such as the NOX genes and C5aR2) were dysregulated in cases of SARS CoV-2 infection. A previous study showed that some viruses trigger NOX-derived Reactive oxygen species secretion by inducing NOX signaling in the very early stages of the viral infection. NOX signaling inhibitors such as diphenyliodonium chloride improve the exaggerated inflammatory responses induced by viral infection [37] . Whether or not these drugs could help SARS CoV-2 patients needs more studies. It worth noting that NOX inhibitors affect the GTP-binding proteins: RAC1/RAC2. RAC2 was also found in the current study to be dysregulated in SARS CoV-2 infection among other genes related to blood coagulation process GO:0007596.

Tumor Necrosis Factor Receptor-Associated Protein 1 (TRAP-1), which was found in the current study to be dysregulated in SARS CoV-2 infection, is also related to cellular response to stress. It plays an important role in mitochondrial integrity and oxidative stress response [38] .

Overproduction of reactive oxygen species after infection and inflammation induces DNA damage and affects epigenetic regulators that are important in normal cell development and J o u r n a l P r e -p r o o f differentiation. Adipocyte Enhancer Binding Protein 2 (AEBP2) is a part of Polycomb repressive complex 2 (PRC2) which is a key epigenetic regulators that maintain transcriptional repression of many genes and plays an important role of some viruses pathogenesis [39] . AEBP2 was found in the current study to be dysregulated in SARS CoV2 infection. Collectively, these data suggests that oxidative stress could be related to COVID-19 pathogenesis.

The small numbers in each group of the studied dataset dictates the necessity of further studies on COVID-19 transcriptome. Several researchers had reported transcriptomic changes in COVID-19 patients in agreement with the results of the current study. COVID-19 patients were reported to have over expression of pro-inflammatory cytokines such as IL-2, IL-6, IL-7, IL-10, granulocyte-colony stimulating factor, interferon-γ inducible protein 10, and TNFα. This was observed to increases the vascular permeability and accumulation of fluid and blood cells into the alveoli, leading to dyspnea and respiratory distress [40, 41] . Another transcriptome profiling study suggested that SARS-CoV-2 RNA could be acting as an RNAi.

This might explain many of the down-regulatory expression effects including its effect on mitochondrial functions [42] . This could support the results of the current study that mitochondrial integrity and oxidative stress response could be affected by SARS CoV-2 infection (through TRAP-1 dysregulation in the current study).

The processes found in the current study to be dysregulated -particularly protein SUMOylation, negative regulation of glucocorticoid biosynthesis and blood coagulationrequire attention especially they could be targeted by already known drugs such as SUMO inhibitor 2-D08, cardiotonic steroids, and Azathioprine, respectively. Also, the role of Cathepsins in viral entry and the role of NOX signaling could be of therapeutic value, perhaps using the NOX signaling inhibitor, diphenyliodonium chloride. 

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

☐ The authors declare the following financial interests/personal relationships which may be considered as potential competing interests

Please note that all Biochemical and Biophysical Research Communications authors are required to report the following potential conflicts of interest with each submission. If applicable to your manuscript, please provide the necessary declaration in the box above.

(1) All third-party financial support for the work in the submitted manuscript.

(2) All financial relationships with any entities that could be viewed as relevant to the general area of the submitted manuscript.

(3) All sources of revenue with relevance to the submitted work who made payments to you, or to your institution on your behalf, in the 36 months prior to submission. (4) Any other interactions with the sponsor of outside of the submitted work should also be reported. (5) Any relevant patents or copyrights (planned, pending, or issued). (6) Any other relationships or affiliations that may be perceived by readers to have influenced, or give the appearance of potentially influencing, what you wrote in the submitted work. As a general guideline, it is usually better to disclose a relationship than not.

Angiotensinconverting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems

STRING v10: protein-protein interaction networks, integrated over the tree of life

PANTHER: a library of protein families and subfamilies indexed by function

The reactome pathway knowledgebase

HIV-1 Nef Hijacks Lck and Rac1 Endosomal Traffic To Dually Modulate Signaling-Mediated and Actin Cytoskeleton-Mediated T Cell Functions

Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion

Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials

Cysteine Cathepsins in Tumor-Associated Immune Cells

Angiotensin II increases expression and secretion of cathepsin F in cultured human monocytederived macrophages: an angiotensin II type 2 receptor-mediated effect

Wild-type human coronaviruses prefer cellsurface TMPRSS2 to endosomal cathepsins for cell entry

The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors

Role for NudC, a dynein-associated nuclear movement protein, in mitosis and cytokinesis

Emerging roles of NudC family: from molecular regulation to clinical implications

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease severe acute respiratory syndrome coronavirus entry

The NLRP3 Inflammasome and IL-1β Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis

TRAP-1, the mitochondrial Hsp90

DNA Oncogenic Virus-Induced Oxidative Stress, Genomic Damage, and Aberrant Epigenetic Alterations

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples